Pneumococcal pneumonia frequency in therapeutic adult inpatients at three Russian Regions

Биличенко, Т. Н.; Аргунова, А. Н.; Антонова, О. А.; Solov'ev, Array K; Gladin, Sergey; Nikitina, N.A.; Лямин, А. В.; Chigishchev, Andrey; Пучкина, Н. Е.

doi:10.18093/0869-0189-2013-0-4-29-36

Cited by 8 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 Other studies demonstrated, that in different Russian regions pneumococcal etiology of pneumonia was confirmed in 10.6-25.9% of hospitalized adult patients. 18 The annual incidence of community acquired pneumonia (CAP) was evaluated in new Russian Army recruits confined in training centers, a group with higher (5-fold) incidence of pneumococcal disease than the general adult population in Russia; the annual incidence of CAP in military camps was 4.2% and reached 20% during outbreaks. 19 Among Russian individuals, the most common serotypes/serogroups associated with CAP were 14 (21.9%), 6B (17.1%), and 23 (17.1%).…”

Section: Introductionmentioning

confidence: 99%

Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects

Ciprero

Zykov

Брико

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects

Ciprero

Zykov

Брико

et al. 2016

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

Modern Aspects of Community-Acquired Pneumonia

Круглякова¹,

Kruglyakova

Нарышкина³

et al. 2019

Bulletin Physiology and Pathology of Respiration

View full text Add to dashboard Cite

Thanks to a large number of studies on community-acquired pneumonia (CAP) by scientists around the world, new data are emerging on various aspects of the problem. Therefore, it is necessary to regularly update knowledge on this issue. Despite the tendency to decrease in recent years, the incidence of CAP is 5-10 cases per 1 thousand of the population. In the structure of the general morbidity of respiratory diseases, CAP ranks 2nd in the adult population and 1st in children. Mortality from CAP ranges from 5% to 25-50% depending on the severity, mechanisms of development and personality of the patient (age, nutritional status, concomitant diseases, immune system, etc.), increasing with the growth of diseases of the upper respiratory tract caused by pneumotropic viruses. The clinical lecture presents current data on the features of etiology, previously little known mechanisms of the pathogenesis of CAP, the clinic of typical bacterial, viral, fungal, mycoplasmic and parasitic CAP, as well as the features of the disease in patients with severe immune disorders (AIDS, other diseases/pathological conditions) and aspiration pneumonia. In short form there are discussed the main recommendations for the treatment of CAP in various clinical groups: outpatients, persons with mild CAP, patients with severe CAP with suspected infection with Pseudomonas aeruginosa and aspiration.

show abstract

A draft national adult immunization calendar in Russia

Брико¹,

Фельдблюм²,

Алыева³

et al. 2018

Profil. med.

View full text Add to dashboard Cite

Вакцинация является главным экономически оправданным средством борьбы с инфекционными заболеваниями и обеспечивает непосредственную защиту от возбудителей инфекционных заболеваний, а также вызывает феномен популяционного иммунитета за счет лиц, обладающих иммунологической памятью против определенной инфекции [1]. 1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздравa России, Москва, Россия; 2 ФГБОУ ВО «Пермский государственный медицинский университет им. акад. Е.А. Вагнера» Минздравa России, Пермь, Россия; 3 Министерство здравоохранения Российской Федерации, Москва, Россия; 4 ФГБУ «Национальный медицинский исследовательский центр профилактической медицины» Минздрава России, Москва, РоссияПриоритет действующего национального календаря профилактических прививок направлен на иммунизацию детского населения, общая концепция иммунизации взрослых отсутствует, что не обеспечивает защиту целевых групп в условиях меняющейся эпидемической ситуации и состояния популяционного иммунитета. Цель исследования -обосновать и разработать национальный календарь профилактических прививок для взрослого населения. Материал и методы. Работа выполнена на основании данных отечественной и зарубежной литературы, оценки эпидемической ситуации среди взрослого населения в РФ и собственных исследований авторов. Результаты. Разработан и обоснован проект национального календаря профилактических прививок для взрослых, состоящий из двух разделов. Первый раздел включает вопросы иммунизации различных возрастных групп, второй -иммунизацию групп эпидемиологического и социального риска. Заключение. Внедрение национального календаря профилактических прививок для взрослых и улучшение организационных основ вакцинопрофилактики обеспечат дальнейшее снижение заболеваемости и смертности в стране.Ключевые слова: календарь прививок, вакцинопрофилактика, взрослые, группы риска.The current national immunization calendar is intended for the pediatric population; the general concept of adult immunization is absent, which does not protect target groups under the conditions of the changing epidemic situation and the state of population immunity. Objective -to substantiate and design a national vaccine schedule for adults. Material and methods. The investigation was conducted using the data available in the Russian and foreign literature, the assessments of the epidemic situation among the adult population in the Russian Federation, and the authors' own studies. Results. The draft national adult immunization calendar consisting of two sections was designed and substantiated. The first section includes information on immunization of different age groups; the second contains that on immunization of groups at epidemiological and social risks. Conclusions. The introduction of the national adult immunization calendar and improvements in the institutional framework of vaccination will achieve further reductions in morbidity and mortality rates in the country.

show abstract

Pneumococcal pneumonia frequency in therapeutic adult inpatients at three Russian Regions

Cited by 8 publications

References 3 publications

Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects

Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects

Modern Aspects of Community-Acquired Pneumonia

A draft national adult immunization calendar in Russia

Contact Info

Product

Resources

About